Log In
Print
BCIQ
Print
Print this Print this
 

CER-522

  Manage Alerts
Collapse Summary General Information
Company Cerenis Therapeutics S.A.
DescriptionPeptide HDL mimetic
Molecular Target Apolipoprotein A-1 (APOA1)
Mechanism of Action 
Therapeutic ModalityPeptide
Latest Stage of DevelopmentPhase I
Standard IndicationRestenosis
Indication DetailsTreat aortic valve stenosis
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today